Company Monitoring Page for Novartis

latest headlines for company on cafepharma

What Novartis could buy with its windfall
EP Vantage
Fri, 11/5/21 - 09:40 am
Tags:
Novartis, M&A, Roche, Sandoz, Aurinia Pharmaceuticals, Alnylam, Exelixis, Incyte, Eisai, Genmab
Novartis to sell its Roche stake for $20.7 billion
Axios
Thu, 11/4/21 - 10:54 am
Tags:
Novartis, Roche
Novartis teams with advocacy group to bring visibility to atherosclerotic cardiovascular disease
Fierce Pharma
Wed, 11/3/21 - 10:36 am
Tags:
Novartis, pharma marketing, patient advocacy groups, atherosclerosis, ASCVD
Novartis makes protein degrader play, inking deal with new British startup to access fruits of novel tech
Fierce Biotech
Tue, 11/2/21 - 10:53 am
Tags:
Novartis, protein degradation, Dunad Therapeutics, biobucks
AbbVie, Janssen, Novartis, Pfizer and UCB to jointly advance 'digital' endpoint for atopic dermatitis
Endpoints
Tue, 11/2/21 - 10:48 am
Tags:
atopic dermatitis, eczema, nocturnal scratch, digital endpoint, AbbVie, Janssen, JNJ, Novartis, Pfizer, UCB Pharma, digital pharma
FDA Approves Scemblix for Pretreated CML in the Chronic Phase
Cure Today
Sat, 10/30/21 - 10:46 pm
Tags:
Novartis, Scemblix, FDA, CML
Novartis dumps Rett gene therapy caught up in Zolgensma scandal in cull of pipeline prospects
Fierce Biotech
Tue, 10/26/21 - 10:41 am
Tags:
Novartis, Rett Syndrome, AVXS-201, Zolgensma, gene therapy
Novartis looking into future of its Sandoz’ generics business
Pharmaforum
Tue, 10/26/21 - 10:30 am
Tags:
Novartis, generics, Sandoz
Novartis hits another setback in plan to repurpose rare disease drug in lung cancer
BioPharma Dive
Mon, 10/25/21 - 11:51 pm
Tags:
Novartis, clinical trials, canakinumab, Ilaris, lung cancer
Novartis has negotiated Zolgensma access for half of the European SMA population, exec says. How'd it get there?
Fierce Pharma
Fri, 10/22/21 - 12:39 pm
Tags:
Novartis, Europe, Zolgensma, SMA, spinal muscular atrophy
Novartis signs new agreement with BioNTech for COVID-19 vaccine fill and finish
Biopharma Reporter
Thu, 10/21/21 - 09:29 am
Tags:
Novartis, BioNTech, vaccines, COVID-19, drug manufacturing
Novartis exec says COVID exposed pharma manufacturing weaknesses. Here's how he plans to fix them
Fierce Pharma
Thu, 10/14/21 - 11:08 am
Tags:
Novartis, drug manufacturing, COVID-19
Three generic firms shell out $447M more to settle federal price fixing allegations
Endpoints
Mon, 10/4/21 - 10:59 am
Tags:
generics, legal, price fixing, Taro Pharmaceuticals, Sandoz, Novartis, Apotex
Novartis tightens up its COVID-19 vaccine policy for staff
Pharmaforum
Sun, 10/3/21 - 08:14 pm
Tags:
Novartis, COVID-19, vaccines, vaccine mandates
A newly private Novartis partner bags a megaround on its first go to turbocharge CAR-T, cell therapy pipeline
Endpoints
Thu, 09/30/21 - 11:04 am
Tags:
Novartis, China, Cellular Biomedicine
Novartis drug raises hope of tackling malaria drug resistance
Pharmaforum
Thu, 09/30/21 - 10:49 am
Tags:
Novartis, malaria, ganaplacide
Oncology the focus for big pharma catalysts
EP Vantage
Tue, 09/28/21 - 11:19 am
Tags:
Big Pharma, cancer, oncology, Merck, Keytruda, AbbVie, Vraylar, Gilead Sciences, Trodelvy, Sanofi, Sarclisa, Novartis, ligelizumab
HHS lines up Novartis, Lilly, AstraZeneca and 3 other drugmakers for fines due to drug discount violations
Endpoints
Fri, 09/24/21 - 12:00 pm
Tags:
HHS, 340B, discounts, Novartis, Eli Lilly, AstraZeneca, Novo Nordisk, Sanofi, United Therapeutics
Novartis reshuffling doesn't portend a pullback from gene therapy, company says
Fierce Pharma
Wed, 09/22/21 - 11:56 am
Tags:
Novartis, gene therapy, AveXis
Novartis acquires Arctos Medical to expand optogenetics portfolio
Biopharma Reporter
Tue, 09/21/21 - 10:50 am
Tags:
Novartis, Arctos Medical, gene therapy, optogenetics

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.